Velcade (Bortezomib) +Melphalan+Prednisone (VMP), Phase 3, Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Newly Diagnosed Multiple Myeloma (NDMM)
### Instruction:
Identify the study with the following condition. 
### Input:
Velcade (Bortezomib) +Melphalan+Prednisone (VMP), Phase 3, Anti-CD38 MAb, Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Newly Diagnosed Multiple Myeloma (NDMM) 
### Output:
Popular Name is ALCYONE, Study ID is NCT02195479